Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal.

Kole D, Grella A, Dolivo D, Shumaker L, Hermans W, Dominko T.

Stem Cell Res. 2017 May;21:106-116. doi: 10.1016/j.scr.2017.04.006. Epub 2017 Apr 18.

2.

Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor.

Vernardis SI, Terzoudis K, Panoskaltsis N, Mantalaris A.

Sci Rep. 2017 Feb 6;7:42138. doi: 10.1038/srep42138.

3.
4.

The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.

Gawlik-Rzemieniewska N, Bednarek I.

Cancer Biol Ther. 2016;17(1):1-10. doi: 10.1080/15384047.2015.1121348. Review.

5.

Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line.

Śmieszek A, Czyrek A, Basinska K, Trynda J, Skaradzińska A, Siudzińska A, Marędziak M, Marycz K.

Biomed Res Int. 2015;2015:769402. doi: 10.1155/2015/769402. Epub 2015 Apr 30.

6.

Prolonged proteasome inhibition cyclically upregulates Oct3/4 and Nanog gene expression, but reduces induced pluripotent stem cell colony formation.

Floyd ZE, Staszkiewicz J, Power RA, Kilroy G, Kirk-Ballard H, Barnes CW, Strickler KL, Rim JS, Harkins LL, Gao R, Kim J, Eilertsen KJ.

Cell Reprogram. 2015 Apr;17(2):95-105. doi: 10.1089/cell.2014.0030. Erratum in: Cell Reprogram. 2015 Aug;17(4):323. Floyd, Elizabeth Z [corrected to Floyd, Z Elizabeth].

7.

Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.

Jez M, Ambady S, Kashpur O, Grella A, Malcuit C, Vilner L, Rozman P, Dominko T.

PLoS One. 2014 Feb 24;9(2):e89546. doi: 10.1371/journal.pone.0089546. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e104296.

8.

Maintenance of multipotency in human dermal fibroblasts treated with Xenopus laevis egg extract requires exogenous fibroblast growth factor-2.

Kole D, Ambady S, Page RL, Dominko T.

Cell Reprogram. 2014 Feb;16(1):18-28. doi: 10.1089/cell.2013.0066. Epub 2014 Jan 3.

9.

Human Embryonic-like ECM (hECM) Stimulates Proliferation and Differentiation in Stem Cells While Killing Cancer Cells.

Pinney E, Zimber M, Schenone A, Montes-Camacho M, Ziegler F, Naughton GK.

Int J Stem Cells. 2011 Jun;4(1):70-5.

10.

FGF2-induced effects on transcriptome associated with regeneration competence in adult human fibroblasts.

Kashpur O, LaPointe D, Ambady S, Ryder EF, Dominko T.

BMC Genomics. 2013 Sep 26;14:656. doi: 10.1186/1471-2164-14-656.

11.

Acute reduction in oxygen tension enhances the induction of neurons from human fibroblasts.

Davila J, Chanda S, Ang CE, Südhof TC, Wernig M.

J Neurosci Methods. 2013 Jun 15;216(2):104-9. doi: 10.1016/j.jneumeth.2013.03.020. Epub 2013 Apr 3.

12.

Expression pattern of pluripotent markers in different embryonic developmental stages of buffalo (Bubalus bubalis) embryos and putative embryonic stem cells generated by parthenogenetic activation.

Singh KP, Kaushik R, Garg V, Sharma R, George A, Singh MK, Manik RS, Palta P, Singla SK, Chauhan MS.

Cell Reprogram. 2012 Dec;14(6):530-8. doi: 10.1089/cell.2012.0032.

13.

Fibroblast growth factor (FGF) signaling during gastrulation negatively modulates the abundance of microRNAs that regulate proteins required for cell migration and embryo patterning.

Bobbs AS, Saarela AV, Yatskievych TA, Antin PB.

J Biol Chem. 2012 Nov 9;287(46):38505-14. doi: 10.1074/jbc.M112.400598. Epub 2012 Sep 20.

14.

Induced pluripotent stem cells to model and treat neurogenetic disorders.

Wang H, Doering LC.

Neural Plast. 2012;2012:346053. doi: 10.1155/2012/346053. Epub 2012 Jul 19. Review.

15.

Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives.

Tobe BT, Hou J, Crain AM, Singec I, Snyder EY, Brill LM.

Stem Cell Rev. 2012 Mar;8(1):16-31. doi: 10.1007/s12015-011-9317-8. Review.

16.

Embryonic stem cells and iPS cells: sources and characteristics.

Hackett CH, Fortier LA.

Vet Clin North Am Equine Pract. 2011 Aug;27(2):233-42. doi: 10.1016/j.cveq.2011.04.003. Epub 2011 Jun 16.

17.

Advancements in reprogramming strategies for the generation of induced pluripotent stem cells.

Lai MI, Wendy-Yeo WY, Ramasamy R, Nordin N, Rosli R, Veerakumarasivam A, Abdullah S.

J Assist Reprod Genet. 2011 Apr;28(4):291-301. doi: 10.1007/s10815-011-9552-6. Epub 2011 Mar 9. Review.

18.

Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.

Ambady S, Malcuit C, Kashpur O, Kole D, Holmes WF, Hedblom E, Page RL, Dominko T.

Int J Dev Biol. 2010;54(11-12):1743-54. doi: 10.1387/ijdb.103192sa.

19.

A combined epigenetic and non-genetic approach for reprogramming human somatic cells.

Han J, Sachdev PS, Sidhu KS.

PLoS One. 2010 Aug 19;5(8):e12297. doi: 10.1371/journal.pone.0012297.

20.

Induced pluripotent stem cells: what lies beyond the paradigm shift.

Cox JL, Rizzino A.

Exp Biol Med (Maywood). 2010 Feb;235(2):148-58. doi: 10.1258/ebm.2009.009267. Review.

Supplemental Content

Support Center